Target type: biologicalprocess
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of the deprivation of oxygen and glucose. [GOC:sl, PMID:21525936]
Cellular response to oxygen-glucose deprivation, also known as anoxia or ischemia, is a complex process involving multiple signaling pathways and cellular adaptations in response to the lack of oxygen and glucose. It is a critical aspect of various physiological and pathological conditions, including stroke, heart attack, and diabetes.
**1. Initial Events:**
* **Energy Depletion:** The absence of oxygen and glucose immediately disrupts ATP production through oxidative phosphorylation, leading to a rapid decline in cellular energy levels.
* **Metabolic Shift:** Cells switch to anaerobic glycolysis, producing lactate and reducing intracellular pH.
* **Ion Channel Dysregulation:** The lack of oxygen and glucose disrupts ion channel activity, leading to membrane depolarization and calcium influx.
**2. Signaling Pathways:**
* **Hypoxia-Inducible Factor (HIF) Pathway:** HIF is a transcription factor that is stabilized under hypoxic conditions. HIF activates genes involved in:
* **Glycolysis:** To increase ATP production from glucose.
* **Angiogenesis:** To promote blood vessel formation and restore oxygen supply.
* **Cell survival:** To protect cells from apoptosis.
* **MAP Kinase Pathway:** This pathway is activated by stress signals and regulates cell growth, proliferation, and survival.
* **Caspase Cascade:** This pathway is involved in programmed cell death (apoptosis) and is triggered by cellular damage.
**3. Cellular Adaptations:**
* **Autophagy:** Cells degrade and recycle cellular components to conserve energy.
* **Mitochondrial Remodeling:** Mitochondria undergo structural changes to adapt to low oxygen levels.
* **Cell Cycle Arrest:** Cells halt their division to conserve energy and prevent further damage.
**4. Outcomes:**
* **Cell Survival:** If the oxygen and glucose deprivation is brief, cells may adapt and survive.
* **Cell Injury:** Prolonged deprivation leads to cellular damage, including:
* **Necrosis:** Cell death caused by irreversible damage.
* **Apoptosis:** Programmed cell death triggered by signaling pathways.
**5. Clinical Relevance:**
Understanding the cellular response to oxygen-glucose deprivation is crucial for developing therapeutic strategies for diseases like stroke, heart attack, and diabetes. Therapies may target:
* **HIF stabilization:** To promote cell survival and angiogenesis.
* **Caspase inhibition:** To prevent apoptosis.
* **Antioxidant therapy:** To protect cells from oxidative stress.
This is a simplified overview of the cellular response to oxygen-glucose deprivation. The specific mechanisms and outcomes vary depending on the cell type, duration of deprivation, and other factors.'
"
Protein | Definition | Taxonomy |
---|---|---|
Microtubule-associated proteins 1A/1B light chain 3A | A microtubule-associated proteins 1A/1B light chain 3A that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9H492] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
novobiocin | novobiocin : A coumarin-derived antibiotic obtained from Streptomyces niveus. Novobiocin: An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189) | carbamate ester; ether; hexoside; hydroxycoumarin; monocarboxylic acid amide; monosaccharide derivative; phenols | antibacterial agent; antimicrobial agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Escherichia coli metabolite; hepatoprotective agent |
dihydronovobiocin | dihydronovobiocin: high affinity for DNA gyrase B; structure given |